COVID‑19 Brand Switching: Expectation on Protective Efficacy

Beuy Joob, Viroj Wiwanitkit

Abstract


Dear Editor, The new available coronavirus disesae COVID‑19 vaccine becomes the new hope for the control of the disease. A recent report showed that the vaccine could induce protection in a large group of vaccinated subjects.

Keywords


COVID‑19; Brand Switching; Protective Efficacy

Full Text:

PDF

References


Mallapaty S. Vaccines are curbing COVID: Data from Israel

show drop in infections. Nature 2021;590:197.

Dyer O. Covid‑19: Countries are learning what others paid for

vaccines. BMJ 2021;372:n281.

Sookaromdee P, Wiwanitkit V. New COVID‑19 vaccines, its

cost and shelf life: A cost effectiveness analysis. Arch Med Res

;52:453.

Mahase E. Covid‑19: Vaccine brands can be mixed in

“extremely rare occasions,” says Public Health England. BMJ

;372:n12